Evidence map›Paper›PMID 42466099›Full record

ArticleInternational journal of endocrinology2026

Causal Associations of Heparin-Binding Growth and Differentiation Factors With Thyroid Cancer: A Two-Sample Mendelian Randomization Study.

Xiwei Zhang, Dongqiang Yang, Yan Liu, Yanzhao Wu, Ping Shi

Abstract read
In one paragraph

Article in International journal of endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiwei ZhangDepartment of Head and Neck Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100034, China, cacms.ac.cn.
Dongqiang YangDepartment of Radiological Intervention, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, 050000, China.
Yan LiuDepartment of Otolaryngology Head and Neck Surgery, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, 050000, China.
Yanzhao WuDepartment of Otolaryngology Head and Neck Surgery, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, 050000, China.
Ping ShiDepartment of Otolaryngology Head and Neck Surgery, The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, 050000, China.ORCID https://orcid.org/0000-0003-2531-7488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Heparin-binding growth and differentiation factors (GDFs) play roles in various cellular processes and are potential contributors to thyroid cancer. Although population-based studies have documented associations between heparin-binding GDFs and thyroid cancer, their causal relationships remain unclear. Methods: A two-sample Mendelian randomization (MR) analysis was conducted using published genome-wide association studies (GWASs) data. The primary method for estimating causal effects was the inverse-variance weighted (IVW) approach, supplemented by multiple sensitivity analyses including weighted median, MR-Egger, and MR-PRESSO. Heterogeneity and outlier effects were systematically evaluated. Additionally, key MR findings were validated at the transcriptomic level using differential expression analysis of data from the Cancer Genome Atlas (TCGA). Results: The IVW method revealed significant causal relationships between midkine levels (OR = 1.2099, 95% CI: 1.013-1.445, Conclusions: Genetically predicted midkine levels and IGF2 were associated with thyroid cancer, and heparin-binding EGF-like growth factor was associated with malignant thyroid neoplasms. Future studies are needed to validate these findings.

Indexed as

heparin-binding EGF-like growth factorheparin-binding growth/differentiation factorsIGF2Mendelian randomizationmidkinethyroid cancer

Identifiers

PMID42466099
PMCPMC13373531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.